Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02269098 · ClinicalTrials.gov registry record · NA
The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes
A NA study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT02269098 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 101 participants.
The verdict
NCT02269098, a NA study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
A 4 week prospective, randomized controlled study was carried out to assess the impact of a care delivery intervention which focused on blood glucose (BG) management among adults with type 2 diabetes presenting to the Emergency Department (ED) with BG \> 200mg/dL (11.1 mmol/L). The intervention was designed by a multi-disciplinary team of ED physicians and nurses, endocrinologists and diabetes educators. The intervention incorporated three components: a guideline-based algorithm for diabetes medication management; survival skills diabetes self-management education (DSME); and support for health system navigation. The control group received usual care per the ED's policies and procedures for management of high blood glucose.
Interventions
- OTHER Diabetes medication management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02269098
The ClinicalTrials.gov registry entry for NCT02269098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diabetes medication management is the first listed.
NCT02269098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02269098 about?
NCT02269098 is a clinical study titled "The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes". A 4 week prospective, randomized controlled study was carried out to assess the impact of a care delivery intervention which focused on blood glucose (BG) management among adults with type 2 diabetes presenting to the Emergency Department (ED) with BG \> 200mg/dL (11.1 mmol/L). The intervention was ...
What is the current status of trial NCT02269098?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2012-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02269098?
The interventions under investigation include: Diabetes medication management (OTHER).
Who is sponsoring clinical trial NCT02269098?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.